Genentech Announces Agreement With U.S. Government

"Today's agreement demonstrates our ongoing commitment to enhancing access to life-changing therapeutics, so patients may benefit from our country's long-term commitment to innovation,†said Ashley Magargee, Chief Executive Officer of Genentech. "As the proud founder of the American biotech industry, we share the goals of the administration to address prescription drug costs and reward innovation. As always, Genentech will continue to seek solutions for lowering patient costs while increasing opportunities f ...